Dermatology State-of-the-Art Issues

D6995

+ Add to Google Calendar + Add to Outlook

This activity is designed for physicians, physician assistants, nurse practitioners, nurses, and other health-care professionals who are interested in an update on advances in the understanding and treatment of skin diseases.

Friday, Oct. 4, 2024

• 7 a.m. | Check-In/Visit Exhibitors
• 7:30 a.m. | Industry-Sponsored Symposium
  (Not for CME credit)
  With Dupixent Change is Achievable in Itch and Skin Lesions
  Saurabh Singh, MD
  US Dermatology Partners, Silver Spring, MD
  Chief Medical Officer, SkinTap Teledermatology
  Assistant Clinical Professor of Dermatology,
  George Washington University School of Medicine and Health Sciences
• 8:30 a.m. | Check-In/Visit Exhibitors
• 8:45 a.m. | Walk to University Physician Center (UPC) for Grand Rounds Patient Viewing
  (UPC location: 200 Campus Dr, Entrance 3, Hershey, PA 17033)
• 9 a.m. | Dermatology Grand Rounds Patient Viewing at the University Physician Center (UPC)
• 9:45 a.m. | Return to University Conference Center

Morning Moderator: Matthew Helm, MD

• 10 a.m. | Discussion of Dermatology Grand Rounds: Resident Patient Cases*
  (Health Care Professionals Only)
  *CME credit offered as part of the Regularly Scheduled Series
• Noon | Grand Rounds Adjournment/Check-In/Visit Exhibitors/Lunch

Afternoon Moderator: Christopher Bazewicz, MD

• 1 p.m. | What’s New in Rheumatology Dermatology – Part 1
  Matthew Helm, MD

  Objectives

  • Discuss new therapeutic options for cutaneous rheumatic disease.
  • Recognize newly described diseases and their cutaneous findings.
• 1:20 p.m. | Updates in Therapeutics for Pediatric Dermatology
  Brian Philip Green, DO

  Objectives

  • Describe newer treatments for atopic dermatitis in the pediatric population.
  • Describe side effects of newer treatments for pediatric patients.
• 1:40 p.m. | Update in Melanoma Immunotherapy
  Bryan Anderson, MD

  Objectives

  • Recognize common medications (PD-1 and CTLA-4 inhibitors) used to treat metastatic melanoma.
  • Discuss the newer therapeutic options (LAG-3 inhibitors and adoptive cell therapy).
• 2 p.m. | What’s New in Hair Loss
  Jeffrey Miller, MD, MBA

  Objectives

  • List new treatments of hair loss.
  • Explain how to prescribe janus kinase (JAK) inhibitors for alopecia areata.
• 2:20 p.m. | Skin of Color Updates
  L. Claire Hollins, MD

  Objectives

  • Describe the common styles of black women’s hair.
  • Explain how to have a successful visit with a black female with hair loss.
  • Discuss treatment recommendations for two common conditions.
• 2:40 p.m. | Update on Acne
  Andrea Zaenglein, MD

  Objectives

  • Review pathogenesis of acne.
  • Discuss latest treatment approaches and options for patients with acne.
• 3 p.m. | Afternoon Break/Exhibitors
• 3:40 p.m. | A New Focus on Organelle Biology in Diseases of Keratin
  Navaneetha (Nav) Krishnan Bharathan, PhD

  Objectives

  • Recognize and appreciate the role of keratin filament and organelle interactions in epidermolysis bullosa simplex.
  • Discuss how advances in imaging techniques reveal novel insights into the pathomechanisms of keratinopathies.
• 4 p.m. | What’s New in Rheumatology Dermatology – Part 2
  Galen Foulke, MD

  Objectives

  • Discuss new therapeutic options for cutaneous rheumatic disease.
  • Recognize newly described diseases and their cutaneous findings.
• 4:20 p.m. | Drug Reactions: Review and Update
  Thomas Helm, MD

  Objectives

  • List the many different skin manifestations of drug reactions.
  • Discuss the latest treatment options for severe drug reactions.
  • Identify recently recognized reactions to novel therapeutic agents.
• 4:45 p.m. | Final Remarks/Adjournment

Saturday, Oct. 5, 2024

• 7 a.m. | Check-In/Visit Exhibitors
• 7:30 a.m. | Industry-Sponsored Symposium
  (Not for CME credit)
  Raising the Bar in Atopic Dermatitis
  Nicole Seminara, MD
  Piedmont Plastic Surgery & Dermatology
  Cornelius, N.C.
• 8:30 a.m. | Check In/Visit Exhibitors

Morning Moderator: Claire Hollins, MD

• 9 a.m. | Shedding Some Light on Lasers
  Todd Cartee, MD

  Objectives

  • Explain laser-tissue interactions to optimize results and minimize adverse events.
  • Identify the right device and right settings to enhance outcomes.
• 9:20 a.m. | Surgical Pearls for General Dermatology
  Kimberly Ken, MD

  Objectives

  • Describe preoperative technique to maximize the patient experience.
  • Review novel operative hemostasis and suturing techniques to enhance a linear closure.
• 9:40 a.m. | Making Sense of Artificial Intelligence in Evaluation of Pigmented Lesions
  Jonathon Zieff, DO

  Objectives

  • Explain the types of available artificial intelligence used in the evaluation of pigmented lesions, and provide the evidence supporting their use.
  • Analyze the strengths, weaknesses and limitations for each of these types of artificial intelligence.
• 10 a.m. | Specialty Mycosis Fungoides (MF) Therapies for the General Dermatologist
  Christopher Bazewicz, MD

  Objectives

  • Discuss how to prescribe/manage 0.016% mechlorethemine gel for MF.
  • Discuss how to prescribe/manage oral retinoids and interferons for MF.
• 10:20 a.m. | Morning Break
• 11 a.m. | Acral Dermatoses – Fortune Teller Says: Part II
  James Marks Jr., MD

  Objectives

  • Discuss how to enhance diagnostic skills of acral dermatoses.
  • List key disease points.
• 11:20 a.m. | Prior Authorization Pearls
  Kelly Gerard, BS Pharm, CSP

  Objectives

  • Identify the prior authorization process from prescribing to approval.
  • Apply specific clinic note documentation to optimize access to medications in dermatology.
• 11:40 a.m. | Drug Development and the Role of Clinicians
  Joslyn Kirby, MD, MS, MEd, FAAD

  Objectives

  • Discuss the roles of health care providers in the development of new therapies, tests, and biotechnology.
  • Review the roles of health care providers in the regulatory aspects of biopharmaceutical and technology industry.
  • Discuss the role of health care providers to provide a bridge between commercial teams and the research and development sector and between the organization and external stakeholders.
• 12:20 p.m. | Final Remarks/Adjournment

Bryan Anderson, MD
Professor and Vice Chair for Clinical Operations, Department of Dermatology
Penn State Cancer Institute
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Christopher Bazewicz, MD
Assistant Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Navaneetha (Nav) Krishnan Bharathan, PhD
Researcher, Department of Dermatology
Penn State College of Medicine

Todd Cartee, MD
Associate Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Galen Foulke, MD
Associate Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Kelly Gerard, BS Pharm, CSP
Clinical Pharmacist, Department of Dermatology
Penn State Health Specialty Pharmacy
Penn State Milton S. Hershey Medical Center

Brian Philip Green, DO
Associate Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Matthew Helm, MD
Assistant Professor, Department of Dermatology and Dermatopathology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Thomas Helm, MD
Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

L. Claire Hollins, MD
Assistant Professor, Department of Dermatology
Vice Chair of Diversity, Equity and Inclusion
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Kimberly Ken, MD
Assistant Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Joslyn Kirby, MD, MS, MEd, FAAD
Senior Medical Director
Inflammation & Autoimmunity Group
Incyte Corporation
Wilmington, DE

Jeffrey Miller, MD, MBA
Professor and Chair, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

James Marks Jr., MD
Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Andrea Zaenglein, MD
Professor, Department of Dermatology and Pediatrics
Penn State Health Milton S. Hershey Medical Center
Penn State Children’s Hospital
Penn State College of Medicine

Jonathon Zieff, DO
Assistant Professor, Department of Dermatology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in up to 5.75 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

The fee is $150 for in-person and $100 for online per person and includes the cost of instruction, online handout materials and all listed meals.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

For a Penn State Health Dermatology staff, Penn State College of Medicine Dermatology resident or Penn State College of Medicine medical student registration discount, please contact the Dermatology Office at 717-531-8307.

Registrations received after Thursday, Oct. 3, will incur a $25 late fee.

Cancellations received after Friday, Sept. 27, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, Oct. 1.

Join us in Hershey

Hershey is conveniently located in central Pennsylvania, just 90 minutes from Baltimore and Philadelphia, two hours from Washington, D.C., and three hours from New York City.

• Harrisburg-Area Attractions
• Hershey Attractions
• Tanger Outlets in Hershey
• Historic Gettysburg
• Pennsylvania Dutch and Amish Country

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D6995